NEW YORK (GenomeWeb) — Medicare contractor Palmetto GBA has issued a final local coverage determination (LCD) for Myriad Genetics' myPath Melanoma test, the firm announced today.
NEW YORK (GenomeWeb) — Medicare contractor Palmetto GBA has issued a final local coverage determination (LCD) for Myriad Genetics' myPath Melanoma test, the firm announced today.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.